🔥The 9th Round of Easy Loan, Earn $40 Reward is in progress❗️ ⏰ Promotion Period: January 15th - Feburary 15th, 2025 👉 Register now and check more details at gate.io/campaigns/358

Has anyone else seen an exceptional response to sorafenib/TKI in #HCC with an activating MTOR mutation? Not finding case reports on this - perhaps because NGS has not been widely used in HCC, historically?

Association of Alcohol Intake With Risk of Early-Onset Colorectal Cancer ascopost.com/news/july-2023… #crcsm #colorectalcancer #alcohol

Excited to present my project evaluating the feasibility of exercise during oxaliplatin infusions in GI malignancies at #ASCOQLTY23 - under great mentorship of Gabriel Brooks. Take away: Patients found exercising DURING oxaliplatin infusions feasible and acceptable!

WHY I (ALMOST) NEVER BOLUS 5-FLUOROURACIL I've been pondering this thread for a while but it's become more urgent in light of another looming chemo shortage <deep sigh>, this time with an imminent dearth of THE foundational drug of GI oncology: 5-fluorouracil, or 5-FU

Tragic case of fatal #5FU toxicity - grateful that Dr. Anil Kapoor’s family has taken this issue public. CBC News: The National Hopefully will push resources for routine DPYD screening 🇨🇦 ➡️BC Cancer adopted DPYD testing in BC last year🙏 ➡️ we need to learn more about variants in

I’ve seen enough (I think). Routine ctDNA is going to be a part of colon cancer surveillance. #GI24

As clinical data starts to accumulate we need a standard definition of “sustained ctDNA clearance”. Lots of immortal time bias going on in some of the ctDNA studies! #GI24

We met with my New Hampshire representatives Sen. Maggie Hassan & Sen. Jeanne Shaheen teams at Washington DC today to discuss about policies impacting cancer care and research funding. We advocate to end drug shortage and to support the CONNECT Health Act #ASCOAdvocacySummit ASCO

Thinking about writing an SBIR grant to fund a clinical decision support tool for oncology practice. The idea is a six-sided die with a different PD-1/PD-L1 inhibitor on each face.

U.S. FDA AACR An important topic being discussed today. It is time to standardize DPYD testing prior to first exposure to fluoropyrimidines. Each story of a DPD-related death is heartbreaking as it could have been prevented with an inexpensive test. #AACRSciencePolicy

Is pubmed down??

Anyone else finding that PubMed is down?

We are recruiting for a GI oncologist to join our team Dartmouth Cancer Center in Lebanon, New Hampshire. Please share with anyone who may be interested, and reach out if you have questions! careers.dhproviders.org/gi-medical-onc…